These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8869003)

  • 1. Does combined therapy of Ca-channel blocker and angiotensin converting enzyme inhibitor exceed monotherapy in renal protection against hypertensive injury in rats?
    Kanno Y; Okada H; Suzuki H; Ikenaga H; Ishii N; Itoh H; Saruta T
    Clin Exp Hypertens; 1996 Feb; 18(2):243-56. PubMed ID: 8869003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive agents and renal protection: calcium channel blockers.
    Saruta T; Kanno Y; Hayashi K; Konishi K
    Kidney Int Suppl; 1996 Jun; 55():S52-6. PubMed ID: 8743511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the timing of initiating antihypertensive therapy in hypertensive rats with renal failure.
    Kanno Y; Okada H; Takenaka T; Saruta T; Suzuki H
    Clin Exp Hypertens; 2000 Jul; 22(5):521-9. PubMed ID: 10937842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease.
    Ecder T; Chapman AB; Brosnahan GM; Edelstein CL; Johnson AM; Schrier RW
    Am J Kidney Dis; 2000 Mar; 35(3):427-32. PubMed ID: 10692268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats.
    Okada H; Suzuki H; Kanno Y; Ikenaga H; Saruta T
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):564-9. PubMed ID: 8569216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of morphological changes in spontaneously hypertensive rats and normotensive Wistar Kyoto rats treated with an angiotensin-converting enzyme inhibitor or a calcium-channel blocker.
    Saleh FH; Jurjus AR
    J Pathol; 2001 Mar; 193(3):415-20. PubMed ID: 11241424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enalapril/amlodipine combination in cyclosporine-treated renal transplant recipients: a prospective randomized trial.
    Halimi JM; Giraudeau B; Buchler M; Al-Najjar A; Etienne I; Laouad I; Bruyère F; Lebranchu Y
    Clin Transplant; 2007; 21(2):277-84. PubMed ID: 17425758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.
    Ishiguro K; Hayashi K; Sasamura H; Sakamaki Y; Itoh H
    Hypertension; 2009 Jan; 53(1):83-9. PubMed ID: 19047581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amlodipine is comparable to angiotensin-converting enzyme inhibitor for long-term renoprotection in hypertensive patients with renal dysfunction: a one-year, prospective, randomized study.
    Kumagai H; Hayashi K; Kumamaru H; Saruta T
    Am J Hypertens; 2000 Sep; 13(9):980-5. PubMed ID: 10981547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis in vasculature of spontaneously hypertensive rats: effect of an angiotensin converting enzyme inhibitor and a calcium channel antagonist.
    Sharifi AM; Schiffrin EL
    Am J Hypertens; 1998 Sep; 11(9):1108-16. PubMed ID: 9752897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes.
    Winer N; Folker A; Murphy JA; Hung E; Bard M; Perkelvald A; Sowers JR; Bakris GL
    Prev Cardiol; 2005; 8(2):87-92. PubMed ID: 15860983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The persistent effect of long-term enalapril on pressure natriuresis in spontaneously hypertensive rats.
    Dukacz SA; Adams MA; Kline RL
    Am J Physiol; 1997 Jul; 273(1 Pt 2):F104-12. PubMed ID: 9249597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats.
    Sharifi AM; Li JS; Endemann D; Schiffrin EL
    J Hypertens; 1998 Apr; 16(4):457-66. PubMed ID: 9797191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
    Hayashi M; Uchida S; Kawamura T; Kuwahara M; Nangaku M; Iino Y;
    Clin Exp Nephrol; 2015 Oct; 19(5):925-32. PubMed ID: 25680887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal protective effects of amlodipine on partially nephrectomized spontaneously hypertensive rats fed a high-salt diet.
    Kanno Y; Suzuki H; Okada H; Saruta T
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):480-4. PubMed ID: 7515994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiproteinuric effects of combined antihypertensive therapies in patients with overt type 2 diabetic nephropathy.
    Kuriyama S; Tomonari H; Tokudome G; Horiguchi M; Hayashi H; Kobayashi H; Ishikawa M; Hosoya T
    Hypertens Res; 2002 Nov; 25(6):849-55. PubMed ID: 12484508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
    Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
    Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal effects of amlodipine.
    Saruta T; Kanno Y; Hayashi K; Suzuki H
    J Hum Hypertens; 1995 Mar; 9 Suppl 1():S11-6. PubMed ID: 7783108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism of telmisartan and amlodipine on blood pressure reduction and cardiorenal protection in hypertensive rats.
    Liu W; Wang W; Song SW; Gu XF; Ma XJ; Su FY; Zhang H; Liu AJ; Su DF
    J Cardiovasc Pharmacol; 2011 Mar; 57(3):308-16. PubMed ID: 21266915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.